Agoracom Blog Home

Author Archive

California Grants #Cannabis Cultivation License to TransCanna $TCAN.ca $VFF.ca $ACB.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 3:24 PM on Saturday, February 20th, 2021
tcan-square

Game-changing achievement for the budding cannabis enterprise

  • Received a highly coveted cultivation license from the State of California that will accelerate the Company’s cultivation capacity almost immediately
  • license represents a major milestone achievement in its endeavors to be California’s leading fully integrated cannabis cultivator, processor, manufacturer, wholesaler and distributor
  • “Obtaining this license is a significant turning point for TransCanna and opens up the door to the explosive growth we’ve been positioning ourselves for,” said Bob Blink

Vancouver, British Columbia–(February 20, 2021) –  TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has received a highly coveted cultivation license from the State of California that will accelerate the Company’s cultivation capacity almost immediately.

The State of California has granted a cultivation license to Lyfted Farms – a TransCanna wholly owned subsidiary – for its flagship Daly facility in Modesto, California. Bob Blink, TransCanna CEO states “Such cultivation licenses in the region are notoriously difficult to obtain. Current applications are back-logged and not even being considered for processing by the county until the end of 2021.”

For TransCanna, the license represents a major milestone achievement in its endeavors to be California’s leading fully integrated cannabis cultivator, processor, manufacturer, wholesaler and distributor.

“Obtaining this license is a significant turning point for TransCanna and opens up the door to the explosive growth we’ve been positioning ourselves for,” said Bob Blink. “Demand has been consistently outstripping supply for our exotic indoor cannabis strains, and now with this new massive facility receiving approval for cultivation, we can finally meet that demand and continue to scale. This will make us one of the largest licensed facilities of its kind in the State of California.”

In addition to cultivation, the new Daly facility empowers TransCanna to increase its scope of offerings and establish its dominance in the California cannabis supply chain.

The Daly facility will anchor other TransCanna operations and serve as a supply chain hub for third party farms across Northern California, offering secure storage, concentrate manufacturing, wholesale market-making, white label services, and State-wide distribution.

Prior to achieving its cultivation license, the facility gained its distribution license in June 2020. Next, TransCanna is eagerly anticipating its processing license (pending approval by the State of California mid to late March) which will qualify the company to dry, cure, trim, grade, and package cannabis onsite. In addition to saving time and money for in-house brands with on-site processing, the processing license will enable TransCanna to open up new revenue streams servicing third party growers.

“California’s cannabis market is $5 billion in sales and growing, and we are well on our way to establishing ourselves at the epicenter of this category with our cultivation, processing, wholesaling and distribution arms of the entire California supply chain,” said Bob Blink, TransCanna CEO.

About TransCanna

TransCanna Holdings Inc. is a California-based, Canadian-listed company building cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

TransCanna’s wholly owned subsidiary Lyfted Farms is California’s authentic cannabis brand whose pioneering spirit has been continuously providing the finest cannabis flower genetics and cultivation methods since 1984. The Lyfted Farms brand of exclusive cannabis flower is sold at premium retailers throughout the state. With its new cultivation facility in Daly, California, the company is now poised to become one of the largest and most efficient vertically integrated cannabis companies in the California market.

Read more: https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/755740-california-grants-cannabis-cultivation-license-to-transcanna/messages/2304595#message

@Novamind_Inc $NM.ca $NVMDF Weekly Roundup $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 9:54 AM on Saturday, February 20th, 2021

A weekly summary of Novamind news and media

FEATURES February 19, 2021

Dr. Reid Robison on Our Purpose-Driven Mission to Help People who are Suffering

Agoracom interviewed our Chief Medical Officer about our latest expansions, the striking results from treatments, and what it takes to build infrastructure for psychedelic-assisted healthcare.

FEATURES February 18, 2021

Novamind Leading the Charge to Deliver Mental Health Alternatives

Psychedelic Invest published an article about the urgent need for innovative mental health treatments, and the companies working to meet that need.

View all media

Novamind Announces Symbol Change on OTC Market To “NVMDF”

February 19, 2021

View all press releases

Follow @novamind_inc on Instagram

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca

@Novamind_Inc $NM.ca Announces Symbol Change on OTC Market To $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 9:13 AM on Friday, February 19th, 2021
  • To commence trading on the OTC Pink Market under the symbol “NVMDF” effective February 19, 2021.
  • The Company’s common shares will continue to trade on the Canadian Securities Exchange under the symbol “NM”.

TORONTO, ON / ACCESSWIRE / February 19, 2021 / Novamind Inc., (CSE:NM)(OTC PINK:NVMDF) (“Novamind” or the “Company”) a mental health company specialized in psychedelic medicine, announces that its common shares, previously listed for trading on the OTC Pink Market in the United States under the symbol “HNLMF”, are to commence trading on the OTC Pink Market under the symbol “NVMDF” effective February 19, 2021. The Company’s common shares will continue to trade on the Canadian Securities Exchange under the symbol “NM”.

Novamind intends to apply to list its common shares on the OTCQB Market in the near future. The OTCQB Market is an established financial market in the United States for promising, investor-focused companies based in America or internationally.

About Novamind

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca.

Read more: https://agoracom.com/ir/Novamind/forums/discussion/topics/755663-novamind-announces-symbol-change-on-otc-market-to-nvmdf/messages/2304371#message

VIDEO – @goplantx $VEGA $PLTXF is the One-Stop-Shop for Everything Plant-Based $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 8:52 AM on Friday, February 19th, 2021
PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) aims to redefine the plant-based community through e-commerce, with a core objective of becoming the most trusted and convenient destination for people living plant-based lives. PlantX is a multifaceted marketplace providing consumers all things plant-based ranging from an efficient e-commerce experience, connecting consumers with interactive PlantX brick-and-mortar stores, and a PlantX home delivery system for products, meals, recipes, and more. Market Outlook With its comprehensive e-commerce platform, PlantX is strongly positioned for a prominent role in both the fast-growing plant-based food market, e-commerce and the online food delivery sectors. The global plant-based food market is expected to reach $74.2 billion by 2027, expanding at a CAGR of 11.9% . Similarly, the online food delivery market has steadily grown, especially during the current pandemic. This trend seems here to stay. In the United States alone, the sector is expected to report $28.5 billion by 2024, with companies such as UberEats experiencing 152% increases in food deliveries in the summer of 2020 . Complementary to these trends, and as a result of the COVID-19 pandemic, online sales and digitization have also both grown exponentially in 2020. Grocery shopping has seen a remarkable transition to e-commerce, with online grocery sales growing by 53% in 2020. Amid the pandemic-imposed physical interactions and related consumer behaviour change, large retailers have been compelled to meet this surge in e-commerce demand. For example, Whole Foods Markets has increased its online sales capacity by over 60% in 2020. The global meal kit delivery system is also becoming increasingly popular, and is expected to achieve $19.92 billion by 2027, expanding at a CAGR of 12.8%. PlantX aims to capitalize on this anticipated exponential market growth of the plant-based, e-commerce and home-delivery industries. Check out this video to find out more about investing in PlantX (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) VISIT OUR OFFICIAL WEBSITE https://plantx.ca/podcasts/​ https://plantx.ca/recipes/​ https://plantx.ca/shops/​ https://plantx.ca/product-category/pl…​ https://plantx.ca/plant-based-meal-de…​ Thanks for watching! We post new LIVE videos every week, so don’t forget to subscribe! LET’S STAY IN TOUCH https://www.tiktok.com/@goplantx​ https://www.facebook.com/goplantx​ https://www.instagram.com/goplantx/​ https://twitter.com/goplantx

Valeo Pharma $VPH $VPHIF to Report Fourth Quarter and 2020 Year-End Results and Hold Investors Conference Call / Webcast $HLS.ca $MDP.ca $GUD.ca $RX.ca

Posted by AGORACOM-JC at 8:19 AM on Friday, February 19th, 2021
Valeo Pharma (@valeo_pharma) | Twitter
  • Valeo will host a conference call to discuss those results and highlights on Thursday February 25, 2021 at 8.30am (EST) .
  • The telephone numbers to access the conference call are 1-888-231-8191 and 647-427-7450.

MONTREAL , Feb. 19, 2021 – Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (” Valeo ” or the ” Company “), a Canadian specialty pharmaceutical company, announced today that it will report its financial results and highlights for the fourth quarter and year ended October 31, 2020 on Wednesday February 24, 2021 after market close.

Valeo will host a conference call to discuss those results and highlights on Thursday February 25, 2021 at 8.30am (EST) . The telephone numbers to access the conference call are 1-888-231-8191 and 647-427-7450. An audio replay of the call will be available. The numbers to access the audio replay are 1-855-859-2056 and 416-849-0833 using the following access code (1498873).

A live audio webcast of the conference call will be available via: https://produceredition.webcasts.com/starthere.jsp?ei=1433860&tp_key=71fe5003d2

VIDEO – Universal PropTech $UPI Secures Investment and Rights To Finger Scan Test Designed To Detect COVID-19 In Less Than A Minute $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 6:04 PM on Thursday, February 18th, 2021

As the name implies “PropTech” is a combination of two words and stands for “property technology.”  As simple as that is, the implementation and importance of PropTech is anything but, which is why many companies are trying to capitalize on the rapidly growing paradigm shift, while Universal PropTech (UPI:TSXV) is actually delivering healthy building solutions developers, owners and operators across Canada. 

More than just lip service, UPI clients include:

· Federal Government facilities for over 40 years 

· Manulife 

· Brookfield 

· Billy Bishop Airport 

· University of Toronto 

· …. and many more 

As a result, UPI has generated $35,000,000+ in revenue over the past 3 year – a number most small cap companies would be very happy with.  But newly appointed Chief Growth Officer, Frank Carnevale sees a much bigger opportunity by winning exclusive licenses and partnerships with providers of great products that can significantly grow company revenues … and he has delivered pretty strongly against this mission statement in 2021. 

BUT TODAY HE TOOK A GIANT LEAP FORWARD 

The press release headline says it all:

Universal PropTech Inc. Invests in and Secures defined Agency Rights for ISBRG Corp.’s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute  

In short, this technology takes a non-invasive scan of a person’s finger with a harmless beam of light designed to provide confirmation of Covid-19 infection in less than 1 minute.  

How significant is this announcement and what does it mean to the Company’s growth? 

Watch our interview with CGO Carnevale to learn all about it. 

VIDEO – Victory Square Technologies $VST.ca $VSQTF Is Spearheading the Fourth Industrial Revolution with a Unique Approach to Start-Up Investment $DBO.ca $NTAR.ca $SEV.ca $YDX.ca

Posted by AGORACOM-JC at 5:44 PM on Thursday, February 18th, 2021

Where does sweet spot lay for the cutting-edge tech that’s shaping the Fourth Industrial Revolution?

For the pioneers at Victory Square Technologies, the solution starts with building, acquiring and investing in promising start-ups, before providing them with the senior leadership and resources needed for fast-track growth.

  • One of those companies is our very own FansUnite (FANS / FUNFF) the small-cap iGaming Super company which hit a 52-week high this week.
  • Acquired for $2m in stock, taken public @ $25m market cap, it currently trades @ $254m market cap.

Highlights:

Across its portfolio of more than 20 global companies, $VST.ca covers:

  • Artificial Intelligence
  • Virtual Reality / Augmented Reality
  • Blockchain
  • Fintech
  • Health-tech
  • Gaming
  • Sports Betting
  • SaaS

And the numbers?

  •  Q3 – Record Net Income of $8.89m and EPS $0.12 cents per share in Q3.
  • 9M – $13.6M and EPS of $0.18 cents for the 9 months ended Sept 2020

The result is rapid scale-up and monetization, with a solid record of public and private exits – including at least two companies listing in 2021.

From its recent acquisition of Hydreight, to the direct listings of Immersive Tech & GameOn, to the string of recent exec appointments including Mike Vorhous and J. Moses… there’s a lot of ground to cover here. 

So, you’re going to want to get comfy for this interview with Shafin Diamond Tejani, CEO and founder of Victory Square Technologies:

VIDEO – As Empower Clinics $CBDT.ca $EPWCF Makes New Highs On Multiple Major Announcements, CEO McAuley Discusses Why $100M Clinic Revenue Is Stage 1 – And Much More Is Coming $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 5:27 PM on Thursday, February 18th, 2021

When we conduct a “Beyond The Press Release” interview, it is always about A press release …. but Empower Clinics has been moving so fast that we sat down with CEO Steve McAuley to discuss these THREE press releases, the explosive growth of the Company and where it is going:

  • Partnership With Rexall To Launch Integrated Health Centres
  • Surpassed 1,000 COVID-19 tests on 1 day for first time ever … 3X Lab Expansion
  • Secured Medical Device Establishment License (MDEL) To Sell KAI Saliva

As usual, Six Sigma Steve McAuley doesn’t disappoint as he confidently and clearly tells investors where Empower Clinics is going next.

PyroGenesis $PYR.ca Provides Update on its Listing Application with #NASDAQ $RTN $NOC $UTX $DDD.ca $HPQ.ca

Posted by AGORACOM-JC at 2:45 PM on Thursday, February 18th, 2021
  • Company is pleased to announce that the United States Securities and Exchange Commission (SEC) has recently approved PyroGenesis’ Shares for listing in the US.
  • The only remaining request from the SEC, before rendering the Company’s Shares effective, is that upon final NASDAQ acceptance, the Company provides the SEC with at least 3 days’ prior notice of its intended listing date.

MONTREAL, Feb. 18, 2021 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY), (the “Company”, the “Corporation” or “PyroGenesis”) a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to provide, further to its Press Release dated February 2 nd , 2021, an update on the Company’s application to list its common shares (“Shares”) on the NASDAQ Stock Exchange (“NASDAQ”). NASDAQ is the second largest exchange by market capitalization worldwide, and is home to many of the world’s best technology companies.

The Company is pleased to announce that the United States Securities and Exchange Commission (SEC) has recently approved PyroGenesis’ Shares for listing in the US. The only remaining request from the SEC, before rendering the Company’s Shares effective, is that upon final NASDAQ acceptance, the Company provides the SEC with at least 3 days’ prior notice of its intended listing date.

With respect to the NASDAQ application, the Company is pleased to announce that it believes it has responded to all questions to the full satisfaction of the exchange. The last outstanding item at this time, before final NASDAQ acceptance, is to have the Company’s Shares become eligible for electronic clearing and settlement through the Depository Trust Company (DTC). DTC eligibility is required in order to create a seamless electronic process of trading and thereby enhance liquidity of the Company’s Shares. This is currently in process with DTC.

As previously disclosed, there will not be a concurrent financing associated with this listing nor will there be a reverse stock split.

“We are pleased to be in the final moments before a NASDAQ listing,” said Mr. P. Peter Pascali, CEO and Chair of PyroGenesis. “We have been extremely satisfied with the increased visibility our recent uplisting to Canada’s premiere exchange, the Toronto Stock Exchange (TSX), has had. We expect this move to NASDAQ will further increase awareness of PyroGenesis and its offerings, both within the financial community and amongst potential clients. Upon final NASDAQ approval, the Board of Directors of PyroGenesis will choose a listing date that will be most beneficial to the Company while taking into consideration other events that are taking place.”

Read More: https://agoracom.com/ir/PyroGenesisCanada/forums/discussion/topics/755616-pyrogenesis-provides-update-on-its-listing-application-with-nasdaq/messages/2304266#message

Universal PropTech $UPI Invests in and Secures defined Agency Rights for ISBRG Corp.’s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 9:57 AM on Thursday, February 18th, 2021
  • ISBRG is a data analytics company which has developed the SpotLight technology platform designed to generate comprehensive health care data non-invasively within seconds at a nominal incremental cost per test.
  • SpotLight-19© is non-invasive, and ISBRG is undertaking trials to determine efficacy in detecting Covid-19.
  • In addition to its minority investment, UPI will act as the exclusive sales agent for the SpotLight-19© technology and other future platform offerings for the government and education sectors in Canada.

Toronto, Ontario–(February 18, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company”) is pleased to announce that it has completed an investment in ISBRG Corp. (“ISBRG”) for a minority interest, and secured agency rights to their SpotLight-19© Technology.

ISBRG is a data analytics company which has developed the SpotLight technology platform designed to generate comprehensive health care data non-invasively within seconds at a nominal incremental cost per test. SpotLight-19© is non-invasive, and ISBRG is undertaking trials to determine efficacy in detecting Covid-19. In addition to its minority investment, UPI will act as the exclusive sales agent for the SpotLight-19© technology and other future platform offerings for the government and education sectors in Canada.

“We are proud and excited to be a strategic investor in ISBRG,” stated Chris Hazelton, President & CEO of Universal PropTech. “We have been committed to ensuring safe and healthy workspaces for our clients and facilitating the return of workers to workspaces in the face of the pandemic, and SpotLight-19© as a rapid, inexpensive and reusable testing platform to ensure safe work environments, could be a catalyst to opening global economies. Upon completion of trials and relevant governmental approvals, Universal PropTech expects that it will aggressively market SpotLight-19© products and supporting services to all governmental and education providers across Canada.”

“Our technology stems from the belief that technological innovation and strategic partnerships will restore economic growth globally in the midst of a pandemic that is challenging the speed, accuracy and effectiveness of existing tests” stated Duncan MacIntyre, Founder and CEO ISBRG.

ISBRG’s SpotLight-19© technology platform has proof of concept, and the funding now enables trials to determine the sensitivity and specificity of the device which will be compared to the accuracy of PCR tests in upcoming trials which are subject to authorization by Health Canada and REB review. Several published studies support ISBRG’s proof of concept and the application of light to detect viruses has been well documented in the past, see (https://pubmed.ncbi.nlm.nih.gov/29806030/).

The global Covid-19 diagnostics market size is estimated at USD$84.4 billion in 2020 and is expected to expand at a compounded annual growth rate (CAGR) of 3.1% from 2021 to 2027[1].

ISBRG headquartered in Mississauga, Ontario, developed its SpotLight-19© technology platform to monitor health – including a Covid-19 state of infection – using patent pending proprietary applications utilizing machine learning, optics and non-invasive interface design.

SpotLight-19© technology platform features:

  • a non-invasive scan of a person’s finger with a harmless beam of light
  • designed to provide confirmation of Covid-19 infection in less than 1 minute
  • low-cost testing.

ISBRG’s SpotLight-19© technology is intended for use in large venues, such as:

  • airports
  • border crossings
  • government buildings
  • schools and campuses
  • entertainment complexes, etc.

Should your organization wish to express an interest in procuring SpotLight-19©, please link and complete the Contact form. https://universalproptech.com/

ISBRG founder Duncan MacIntyre, is the former President of ICI in Canada and Latin America, the founding President of the National Quality Institute and co-author of more than 25 US patents in the field of spectroscopy. He has assembled a team of medical doctors, Ai specialists, hardware designers, internationally recognized optics experts and an ISBRG Board of Advisors that excel in their respective fields. The Board of Advisors includes:

  • former Global VP of AMGEN – Michael Kelly
  • former Canadian Astronaut and Author – Commander Chris Hadfield
  • former Director of Emera and Order of Canada appointee – Irene d’Entremont
  • former President of American Eagle Airlines – Peter Bowler
  • former Director General Global Operations CSIS – Allan MacDougall

Michael Kelly, former AMGEN Global VP, Thousand Oaks, California, states: “I became involved in ISBRG because of SpotLight-19©’s Ai and optical design innovations which, subject to confirmation in these trials, have the potential to significantly impact the global economic recovery more than any other technology available today”.

Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/755586-universal-proptech-inc-invests-in-and-secures-defined-agency-rights-for-isbrg-corp-s-spotlight-19-c-technology-designed-to-detect-covid-19/messages/2304191#message